Your Search
- All results
- Pages
- Articles in the press
- Brochures
- Company news
- Educational resources
- News
- Podcasts
- Press releases
- Videos
- Events
Don’t Forget About the Patient
Pharma manufacturers are not embracing patient-centric design when it comes to formulation. We need to go beyond tablets and capsules.Designing products that cater to the needs of those who use them seems logical for any competitive market. Yet tablets and capsules, which cause problems for …
Conventional Tablets May No Longer Be the Go-To-Solution
Market study reveals difficulties swallowing tablets wide-spread and opens up new revenue opportunitiesPullach, Germany, September 2, 2014 – Hermes Pharma, the expert in the development and production of user-friendly solid oral dosage forms, today announced the findings of an international survey exploring the nature of difficulties …
HERMES PHARMA Completes Successful Routine FDA Inspection of Production Facility
Inspection Opens Door for HERMES PHARMA to Increase Production of User-friendly Solid Oral Dosage Forms for the USPullach, Germany, June 26, 2013 HERMES PHARMA, a division of HERMES Arzneimittel GmbH and Europe’s largest developer and manufacturer of user-friendly solid oral dosage forms, recently completed a successful …
Creating User-Friendly Oral Dosage Forms
The use of electronic tongue technology helps firms reduce development times and costs by overcoming challenges associated with traditional testing panels.Ensuring medicines taste pleasant is necessary to achieve high levels of patient compliance, and this is especially important for user-friendly formulations which are tasted more …
Swallowing Tablets is a Massive Problem for Growing Numbers of People
User-Friendly Dosage Forms Enable Pharmaceutical Companies to InnovatePullach, Germany, April 24, 2013 While the pharmaceutical industry concentrates on developing new ever more effective compounds, the basic needs of patients go often ignored. Historically, because of low cost, simplicity and public familiarity, oral application became the main …
New Taste-Masking Technologies Facilitate User-Friendly Pharmaceuticals
Odor and taste are key for the acceptance of dosage forms that dissolve in the mouth. Hermes Pharma, INNOJET Herbert Hüttlin, RCPE and Karl Franzens University research new approaches to increase patient compliance and improve production processes.Pullach, Germany, September 6, 2012 – Hermes Pharma, the expert …
A User-Friendly Approach to Developing an Extended-Release Product
The challenge of achieving sustained delivery of an active ingredient or nutrient can be achieved with extended-release formulations.To treat many conditions effectively, it can be beneficial for the active pharmaceutical ingredient or nutrient to be delivered to the body over a prolonged period of time. …
Oxford Pharmascience and HERMES PHARMA partner to develop new Ibuprofen product
Heads of Terms signed for a range of OXP zero ibuprofen productsOxford Pharmascience, the specialty pharmaceutical company that uses advanced pharmaceutic technologies to reposition medicines, today announces it has signed a Heads of Terms agreement with HERMES PHARMA to license and develop a range of …
Improving the granule strength of roller-compacted ibuprofen sodium for hot-melt coating processing
Solvent-free hot-melt coating processing is a novel and cost-efficient approach to manufacturing taste-masked multiparticulate systems. However, most API powders are fine and cohesive and not processable by hot-melt coating. The aim of this study was to produce dense and abrasion-resistant granules with high drug content …
HERMES PHARMA presents poster on Hot Melt Coating for immediate-releasse orally disintegrating granules
HERMES PHARMA attended the 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology which took place in, Glasgow, United Kingdom from April 4 to 7, 2016. The conference and its accompanying exhibition take place every second year and provide a cross-disciplinary platform for pharmaceutical scientists working in …